Philip Morris International has proved it can move new products through the Food and Drug Administration’s authorization processes. With margins expanding thanks to smokeless tobacco products and ...

Philip Morris offers a secure, above-market dividend yield with robust, near double-digit growth potential for years to come.

Philip Morris International Inc. (NYSE:PM) has received FDA authorization for 11 nicotine-pouch products, bolstering its ...

Philip Morris International Inc. PM continues to advance its smoke-free transformation, with regulatory progress in the United States adding another potential growth lever. The FDA has authorized ...

Philip Morris International is a wide-moat stock with significant upside due to its best-in-class smoke-free product portfolio and international exposure. The company's acquisition of Swedish Match ...

Stifel analyst Matthew E. Smith reiterated a Buy rating on Philip Morris International Inc (NYSE:PM), raising the price forecast to $145 from $138. Yesterday, the Marlboro maker reported third-quarter ...

Detailed price information for Philip Morris International (PM-N) from The Globe and Mail including charting and trades.

Philip Morris shares have more room to run as the Marlboro maker continues to shift its focus from cigarettes to smoke-free products, according to Goldman Sachs. Analyst Bonnie Herzog has a $150 price ...

The stock of tobacco giant Philip Morris International (PM) has surged over the past 12 months due largely to strong financial results and accelerating sales of its non-smoke products. Personally I’m ...

Philip Morris International sells smoke-free and combustible products across 170 global markets, driven by its Iqos and ZYN brands. The company relies on a network of distributors, with two specific ...